Carlsmed (CARL) Other Operating Expenses (2024 - 2026)

Carlsmed (CARL) has reported Other Operating Expenses for 3 consecutive years, with $6.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Other Operating Expenses rose 45.19% year-over-year to $6.0 million; the trailing twelve-month figure through Jun 2026 stood at $20.9 million (up 45.73% YoY), and the FY2025 full-year result was $17.0 million, up 18.98% from the prior year.
• Other Operating Expenses grew to $6.0 million in Q2 2026 per CARL's latest filing, from $5.2 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $6.0 million in Q2 2026 and bottomed at $3.0 million in Q4 2024.
• Historically, Other Operating Expenses has averaged $4.4 million across 3 years, with a median of $4.2 million in 2025.
• The widest YoY moves for Other Operating Expenses: up 74.59% in 2025, down 4.05% in 2025.
• Over 3 years, Other Operating Expenses stood at $3.0 million in 2024, then surged by 74.59% to $5.3 million in 2025, then grew by 14.74% to $6.0 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $6.0 million, $5.2 million, and $5.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.